New Treatment Guidelines for Diabetes

Sharing is caring!

Clinical Context

The American Diabetes Association (ADA) has just published its standards of medical care in diabetes for 2018, and of course, it includes a discussion of glycemic targets. For most patients, the ADA is comfortable with a target glycated hemoglobin (HbA1c) level of less than 7%. However, for younger patients without a history of significant hypoglycemia or cardiovascular disease, an HbA1c goal of less than 6.5% may be appropriate. Conversely, more frail adults with a history of severe complications of diabetes and a high risk for hypoglycemia may be treated more effectively to a target HbA1c level of less than 8%.

The target preprandial plasma glucose level should be 80 to 130 mg/dL for most patients, and the peak postprandial glucose level should not exceed 180 mg/dL. Many pharmacologic interventions are available to achieve these targets, but what is the best practice in choosing these agents? A significant section of the current recommendations focuses on this question.

Ingresa aquí: https://www.medscape.org/viewarticle/891352

Share

Leave a Comment